Uncertainty is the new normal in biotech and pharma. At @meetclora, we explore how leaders are shifting to flexible, dynamic talent strategies to stay resilient in a volatile world. Read our latest report on adapting to change: https://t.co/q6Gub63WjA
Join me on the @Biotech2050Pod podcast with Kristin Yarema, President & CEO of @PoseidaThera. We discuss corporate culture, Allogeneic CAR-T therapies, and bridging the gap between physicians’ visions for medicine and investor priorities.
🔥 Host @rahulc explores bold biotech breakthroughs with Kristin Yarema, President & CEO of @PoseidaThera. From redefining cell therapy to inspiring leadership insights, this is a must-listen on the future of medicine! 🎧 https://t.co/Yt3ycl2fQV #Biotech2050#CellTherapy
Join me on the @Biotech2050Pod podcast with Bharatt Chowrira & @EricElenko of @PureTechH. We dive into their model for tackling big problems, the founding of @KarunaTx, and the benefits of evergreen funding.
Dive into the latest #Biotech2050 episode! Host @rahulc joins Bharatt Chowrira, CEO & @EricElenko, Co-Founder & President of @PureTechH as they share lessons on innovative R&D, tackling challenges, & Karuna Therapeutics' journey. Listen: https://t.co/McUWF2EE5l #Biotech#Podcast
I spoke with Abe Ceesay, CEO of Rapport Therapeutics, on what it takes to scale talent, lead with a servant mindset, and drive smart risk-taking in biotech. Hear his take on building emotional safety and more.
✨ Ready for the future of precision neuroscience? Abe Ceesay, CEO of Rapport Therapeutics, & #Biotech2050 host @rahulc dive into treatments for neurological disorders like focal epilepsy. Don’t miss these insights! Listen: https://t.co/gIsnfcc6AQ
#PrecisionNeuroscience#biotech
Had a great conversation with @dave_bearss, CEO of @Halia_Tx, about the founding of the company, how their initial focus on the APOE4 gene led them to focus on inflammation, and their non-traditional financing strategy for clinical stage assets. Tune in.
Don't miss this #Biotech2050 episode! @dave_bearss, CoFounder & CEO of @Halia_Tx, shares how they're leading the fight against Alzheimer’s w/ pioneering genetic discoveries & innovative therapies. Hosted by @rahulc Listen: https://t.co/2L76iNKEM0
#BiotechPodcast#AlzheimersCure
Excited to have Ken Keller, President & CEO of @DaiichiSankyoUS, on #Biotech2050 with @rahulc! 🎙️ We discuss the future of cancer therapies, innovative ADCs, and insights into partnerships and team building. Listen to the episode: https://t.co/Rp0N501wfP #Biotech#CancerResearch
It was great catching up with @Ptipirneni of @MorphicTx on the new episode of @Biotech2050Pod.
Learn about his journey to being a first-time CEO, integrin #biology, the role of BD in #biopharma, and key drivers leading to the growing potential in the #autoimmune space.
Join @rahulc and Praveen Tipirneni, CEO of Morphic Therapeutic , as they delve into the future of autoimmune therapies and driving innovation in biotech. Don't miss this insightful discussion! #Biotech#AutoimmuneTherapies#Innovation
Listen now: https://t.co/spTIvuL5b5
I will be at #BIO2024 next week discussing industry innovations for @Biotech2050Pod and sharing how @meetclora is derisking #drugdevelopment by modernizing operating models and #hiring.
If you'll be attending, let's meet! Send me a message to schedule time to connect.
Excited to share the latest @Biotech2050 episode with Robert Ang, CEO of @VorBio.
We discussed his journey from #medicine to #VC to #entrepreneurship, next-gen #cancer therapies, and his approach to indication selection. Huge thanks to Robert for his insights!
Excited to have Robert Ang, CEO of Vor Bio, on the latest episode of #Biotech2050 hosted by @rahulc! 🎙️ Tune in as we discuss the future of cancer therapies. Don't miss out! #Biotech#CancerResearch#Innovation
Listen to the episode: https://t.co/XF6AiTuVBf
Biotech faced big layoffs in Q1 of this year, with 57 companies affected, matching Q1 2023 but up 90% from 2022: https://t.co/67SqzFE6cy
How are you navigating the current environment? What does the future of work in #biotech look like? Comment or message me.
Heading to #BIO2024 in San Diego in a few weeks! Excited to meet with industry leaders and discuss how @meetclora is solving some of the biggest challenges teams face today.
Send me a message if you want to meet up!
Court rulings dismissed recent challenges by Bristol Myers Squibb & Johnson & Johnson against the US Inflation Reduction Act's pricing rules. This marks a defining moment for the future of drug development and healthcare advancements.
https://t.co/PhUiQqoIgj
We created Clora after spending years being frustrated with the processes of hiring flexible life science experts. Learn more about our mission - https://t.co/qPrlPc0ysE #pharma#biopharma#biotech#lifesciences
We are excited to announce the launch of The Clora Blog, a resource dedicated to sharing insights on how to consult, build, and lead teams in the life science industry! Subscribe for new posts every week - https://t.co/ekJMhl0eS3
Because hiring life science consultants is faster and easier than ever, companies will be able to piece together the perfect team of experts with extreme agility. Here's how to assemble yours - https://t.co/h2Y365Aii8